Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.625
+0.025 (1.56%)
At close: Dec 5, 2025
Stenocare Revenue
Stenocare had revenue of 1.92M DKK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 5.67M, up 183.98% year-over-year. In the year 2024, Stenocare had annual revenue of 2.23M, down -40.60%.
Revenue (ttm)
5.67M
Revenue Growth
+183.98%
P/S Ratio
12.37
Revenue / Employee
709.22K
Employees
8
Market Cap
70.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.23M | -1.53M | -40.60% |
| Dec 31, 2023 | 3.76M | -731.58K | -16.30% |
| Dec 31, 2022 | 4.49M | 2.60M | 137.54% |
| Dec 31, 2021 | 1.89M | 1.69M | 852.38% |
| Dec 31, 2020 | 198.45K | -4.74M | -95.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 315.60B |
| Coloplast | 27.87B |
| Genmab | 24.48B |
| H. Lundbeck | 24.08B |
| Demant | 22.59B |
| GN Store Nord | 17.12B |
| Zealand Pharma | 9.16B |
| Bavarian Nordic | 6.89B |